BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs6983267
,
IL1A
,
calcium channel activity
,
Diabetes mellitus
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
apolipoprotein II
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
OMIM - Metabolic disease
Explore Curated Studies Results
Literature
Most Relevant Literature
Macrophages in the reticuloendothelial system inhibit early induction stages of mouse apolipoprotein…
Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II.
APOA2: New Target for Molecular Hydrogen Therapy in Sepsis-Related Lung Injury Based on Proteomic an…
Exercise suppresses mouse systemic AApoAII amyloidosis through enhancement of the p38 MAPK signaling…
Proteomic data show an increase in autoantibodies and alpha-fetoprotein and a decrease in apolipopro…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients
Apolipoprotein D (ApoD) In Human Serum As Marker Of Parkinson's Disease
Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients W…
Do Apolipoprotein E Polymorphisms Influence Risk of Cognitive Decline by Modulating Omega-3 Fatty Ac…
A Study of Alirocumab in Participants With Autosomal Dominant Hypercholesterolemia (ADH) and Gain-of…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ